potassium hydrogen carbonate + sodium alginate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
potassium hydrogen carbonate + sodium alginate: clinical details
Prescribing considerations
- Confirm that symptoms are consistent with reflux; persistent, recurrent or atypical symptoms require clinical review.
- Consider sodium and potassium exposure in renal impairment, heart failure and restricted-salt or controlled-potassium diets.
- Calcium carbonate content warrants caution with hypercalcaemia, nephrocalcinosis or recurrent calcium-containing renal calculi.
- Children under 12 years should use the selected suspensions only on medical advice.
Contraindications and cautions
- Known or suspected hypersensitivity to an active ingredient or excipient, including specified parahydroxybenzoates.
Monitoring
- No routine laboratory monitoring is specified for occasional use.
- Review persistent symptoms and reassess renal function, cardiovascular status and dietary electrolyte restrictions where clinically relevant.
Clinical pharmacology
The formulation reacts with gastric acid to produce a buoyant alginate raft that mechanically suppresses reflux and may entrap pepsin and bile. Its therapeutic action is local and physical rather than dependent on systemic absorption.
Formulation and product differences
- The selected products are white or cream oral suspensions available with peppermint or aniseed flavouring.
- Peppermint formulations contain peppermint oil; aniseed formulations contain star anise oil.
- Both selected formulations share the same active ingredients and clinically relevant sodium, potassium, calcium carbonate and parahydroxybenzoate considerations.
potassium hydrogen carbonate + sodium alginate preparations and strengths
Oral suspension
Route: Oral
Strengths: 1000 mg + 200 mg + 10 mg, 1000 mg + 200 mg/10 mL
potassium hydrogen carbonate + sodium alginate interactions
This product may reduce or delay absorption of other oral medicines, so separate administration is recommended.
Tetracycline antibiotics
Absorption of the antibiotic may be reduced.
Fluoroquinolone antibiotics
Gastrointestinal absorption may be reduced.
Sources
These sources were used to prepare and review this medicine page.
Acidex Advance/Boots Advance/Care Advance/Numark Heartburn & Indigestion Relief Peppermint 1000 mg/200 mg/ 10 mg Oral Suspension — Current selected SmPCSummary of Product Characteristics · emc
Acidex/Care/Numark Advance Heartburn & Indigestion Relief Aniseed 1000 mg/200 mg /10 ml Oral Suspension — Current selected SmPCSummary of Product Characteristics · emc
NHSNHS medicine guidance · NHS
NHS Specialist Pharmacy ServiceNHS medicine guidance · NHS Specialist Pharmacy Service
Prepared and reviewed by the iatroX editorial team.